H33Q (p.His33Gln) variant of SERPINC1 (Antithrombin-III)

H33Q (p.His33Gln) in SERPINC1 (Antithrombin-III) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.17 / 1. The record also includes population frequency data and structural context.

H33Q (p.His33Gln) variant details